Lab-grown beating heart cells identify potential drug to prevent COVID-19-related heart damage
Patients with underlying heart problems are more than four times as likely to die from COVID-19
Patients with underlying heart problems are more than four times as likely to die from COVID-19
Low-cost device lets consumers check themselves for multiple strains of SARS-CoV-2 at home
The fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories
The Amulet is the first and only minimally invasive treatment option to offer immediate closure of the left atrial appendage, so blood-thinning medication isn't needed following implantation
The new intuitive interface provides step-by-step guidance to enhance ease of use
Gain insight into how syndromic testing can improve pathogen detection, lead to better-informed treatment plans, and aid antimicrobial stewardship
Gain insights on hot topics ranging from SARS-CoV-2 variants to the fundamentals of fluorescence and confocal microscopy
Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells
Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells
Findings explain higher risk of heart attack in people with diabetes, even after treatment
The drug aims to treat patients with myelodysplastic syndromes
Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers
Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment
The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients
LGC has been working with NHS Test and Trace to support the UK's response to the pandemic